explore -WSS

explore

author：explore 2025-10-01 23:07:17 - browse：97

Novo Nordisk Denmark — LISELOTTE SABROE/AFP/Getty Images

A pill being developed by Danish drugmaker Novo Nordisk may lead to greater weight loss than the obesity therapy Wegovy, the company reported Thursday, citing early data.

In a Phase 1 trial, participants experienced an average of 13.1% weight loss after 12 weeks of taking the experimental oral medicine amycretin, according to data presented at an investor meeting. In comparison, in an earlier Phase 3 trial of the injectable drug Wegovy, people taking Wegovy lost about 6% of their body weight over the same time period.

Novo Nordisk has been on a mission to capitalize on its success with Wegovy, which brought in $4.5 billion in sales last year. (The drug is also sold as a diabetes treatment under the name Ozempic. That version of the drug brought in another $14 billion in sales).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Editas, Vertex strike deal on CRISPR

leisure time

WSS

Megan Rapinoe shares emotional post following US Women's World Cup exit

Illinois Supreme Court finds assault weapons ban constitutional

After Optum profits sink, UnitedHealth makes changes

Prime Medicine, Myeloid Therapeutics clash over genome

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

Surge in Apellis stock fueled by confidence in safety of its eye drug

focus

explore

hotspot

Apple is now the first public company to be valued at $3 trillion

What to know about the judge who will handle the Trump case

State Dept. review finds Biden bears some blame for Afghanistan failures

What to know about the judge who will handle the Trump case

Wildfire smoke exposes gaps in outdoor worker protections

Montana youths win climate lawsuit against state for promoting fossil fuels

Medical records are filled with copy

Biden administration begins canceling student loan debt for 804,000 borrowers

Sports medicine is finally prioritizing gender equality

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

hotspot

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Prime Medicine, Myeloid Therapeutics clash over genome

Schizophrenia gene found to be linked to cells' energy dysfunction

Why health care costs have stayed mostly flat since 2010

Indictment alleges Trump's ex

Why health care costs have stayed mostly flat since 2010

entertainment

hotspot

leisure time

hotspot